An update on the implications of cyclin D1 in melanomas
- PMID: 32147907
- DOI: 10.1111/pcmr.12874
An update on the implications of cyclin D1 in melanomas
Abstract
Cyclin D1 is a protein encoded by the CCND1 gene, located on 11q13 chromosome, which is a key component of the physiological regulation of the cell cycle. CCND1/cyclin D1 is upregulated in several types of human tumors including melanoma and is currently classified as an oncogene that promotes uncontrolled cell proliferation. Despite the demonstrated importance of CCND1/cyclin D1 as a central oncogene in several types of human tumors, its knowledge in melanoma is still limited. This review examines data published on upregulation of the CCND1 gene and cyclin D1 protein in the melanoma setting, focusing on the pathways and molecular mechanisms involved in the activation of the gene and on the clinical and therapeutic implications.
Keywords: CCND1; cyclin D1; melanoma; skin carcinogenesis.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Cyclin D1 and D3 expression in melanocytic skin lesions.Arch Dermatol Res. 2010 Sep;302(7):545-50. doi: 10.1007/s00403-010-1054-3. Epub 2010 May 23. Arch Dermatol Res. 2010. PMID: 20496072 Free PMC article.
-
Diagnostic application of cyclin D1 fluorescent in situ hybridization for histologically undetermined early lesions of acral melanoma in situ: A case series.Ann Diagn Pathol. 2021 Feb;50:151681. doi: 10.1016/j.anndiagpath.2020.151681. Epub 2020 Dec 13. Ann Diagn Pathol. 2021. PMID: 33341705
-
CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.Diagn Pathol. 2021 Jul 5;16(1):60. doi: 10.1186/s13000-021-01116-0. Diagn Pathol. 2021. PMID: 34225728 Free PMC article.
-
An update on the implications of cyclin D1 in oral carcinogenesis.Oral Dis. 2017 Oct;23(7):897-912. doi: 10.1111/odi.12620. Epub 2017 Mar 31. Oral Dis. 2017. PMID: 27973759 Review.
-
Clear cell melanoma: a cutaneous clear cell malignancy.Arch Pathol Lab Med. 2014 Oct;138(10):1328-36. doi: 10.5858/arpa.2014-0307-CC. Arch Pathol Lab Med. 2014. PMID: 25268196 Review.
Cited by
-
Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study.Curr Oncol. 2021 Nov 16;28(6):4756-4771. doi: 10.3390/curroncol28060401. Curr Oncol. 2021. PMID: 34898573 Free PMC article.
-
Prognostic and Clinicopathological Significance of CCND1/Cyclin D1 Upregulation in Melanomas: A Systematic Review and Comprehensive Meta-Analysis.Cancers (Basel). 2021 Mar 15;13(6):1314. doi: 10.3390/cancers13061314. Cancers (Basel). 2021. PMID: 33804108 Free PMC article. Review.
-
Cyclin D1 and PRAME expression in distinguishing melanoma in situ from benign melanocytic proliferation of the nail unit.Diagn Pathol. 2022 Apr 28;17(1):41. doi: 10.1186/s13000-022-01218-3. Diagn Pathol. 2022. PMID: 35484605 Free PMC article.
-
[MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting CCND1].Nan Fang Yi Ke Da Xue Xue Bao. 2022 May 20;42(5):712-717. doi: 10.12122/j.issn.1673-4254.2022.05.12. Nan Fang Yi Ke Da Xue Xue Bao. 2022. PMID: 35673915 Free PMC article. Chinese.
-
Cyclin F Downregulation Affects Epithelial-Mesenchymal Transition Increasing Proliferation and Migration of the A-375 Melanoma Cell Line.Cancer Manag Res. 2020 Dec 22;12:13085-13097. doi: 10.2147/CMAR.S279169. eCollection 2020. Cancer Manag Res. 2020. PMID: 33376401 Free PMC article.
References
REFERENCES
-
- Ackermann, J., Frutschi, M., Kaloulis, K., McKee, T., Trumpp, A., & Beermann, F. (2005). Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Research, 65, 4005-4011.
-
- Aggarwal, P., Vaites, L. P., Kim, J. K., Mellert, H., Gurung, B., Nakagawa, H., … Diehl, J. A. (2010). Nuclear cyclin D1/CDK4 kinase regulates CUL4 expression and triggers neoplastic growth via activation of the PRMT5 methyltransferase. Cancer Cell, 18, 329-340.
-
- Akbani, R., Akdemir, K. C., Aksoy, B. A., Albert, M., Ally, A., Amin, S. B., … Zou, L. (2015). Genomic classification of cutaneous melanoma. Cell, 161, 1681-1696.
-
- Alekseenko, A., Wojas-Pelc, A., Lis, G. J., Furgał-Borzych, A., Surówka, G., & Litwin, J. A. (2010). Cyclin D1 and D3 expression in melanocytic skin lesions. Archives of Dermatological Research, 302, 545-550.
-
- Alonso, S. R., Ortiz, P., Pollán, M., Pérez-Gómez, B., Sánchez, L., Acuña, M. J., … Rodríguez-Peralto, J. L. (2004). Progression in cutaneous malignant melanoma is associated with distinct expression profiles: A tissue microarray-based study. American Journal of Pathology, 164, 193-203.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials